Fredun Pharmaceuticals Ltd
FREDUNFredun Pharmaceuticals Ltd
FREDUNPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
21.78 | 3.11 | 0.09% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
52.29 | 6.68 | 0.47% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Fredun Pharmaceuticals Ltd. is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical formulations. The Company’s products include I V fluids, disposable syringes, infusion sets, surgical gloves and cottons etc.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 43.18 | 58.61 | 59.71 | 97.40 | 113.29 | 135.29 | 226.09 | 276.50 | 349.08 | 365.84 | ||||||||||
Raw Materials | 31.25 | 34.20 | 42.98 | 65.96 | 86.12 | 100.60 | 176.45 | 245.57 | 282.42 | 324.07 | ||||||||||
Power & Fuel Cost | 1.17 | 1.64 | 1.65 | 3.10 | 3.21 | 3.32 | 3.68 | 3.17 | 4.03 | |||||||||||
Employee Cost | 3.83 | 4.92 | 5.19 | 8.04 | 8.95 | 8.66 | 10.66 | 11.54 | 12.50 | |||||||||||
Selling & Administrative Expenses | 4.52 | 6.57 | 5.66 | 9.83 | 6.43 | 7.80 | 12.76 | 14.55 | 20.77 | |||||||||||
Operating & Other expenses | -2.29 | 6.04 | -1.64 | -0.14 | -0.27 | 5.33 | 7.04 | -27.93 | -9.55 | |||||||||||
EBITDA | 4.70 | 5.24 | 5.87 | 10.61 | 8.85 | 9.58 | 15.50 | 29.60 | 38.91 | 41.77 | ||||||||||
Depreciation/Amortization | 0.80 | 1.14 | 1.29 | 1.33 | 1.88 | 2.00 | 2.16 | 2.81 | 3.80 | 3.94 | ||||||||||
PBIT | 3.90 | 4.10 | 4.58 | 9.28 | 6.97 | 7.58 | 13.34 | 26.79 | 35.11 | 37.83 | ||||||||||
Interest & Other Items | 2.06 | 1.87 | 1.94 | 3.13 | 4.48 | 4.37 | 4.74 | 9.28 | 13.65 | 14.95 | ||||||||||
PBT | 1.84 | 2.23 | 2.64 | 6.15 | 2.49 | 3.21 | 8.60 | 17.51 | 21.46 | 22.88 | ||||||||||
Taxes & Other Items | 0.77 | 0.80 | 0.89 | 1.70 | 0.59 | 1.20 | 2.26 | 6.70 | 5.83 | 5.54 | ||||||||||
Net Income | 1.07 | 1.43 | 1.75 | 4.45 | 1.90 | 2.01 | 6.34 | 10.81 | 15.63 | 17.34 | ||||||||||
EPS | 4.46 | 5.97 | 6.01 | 12.00 | 4.76 | 5.04 | 15.06 | 24.12 | 33.86 | 36.90 | ||||||||||
DPS | 0.60 | 0.60 | 0.60 | 0.65 | 0.66 | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 | ||||||||||
Payout ratio | 0.13 | 0.10 | 0.10 | 0.05 | 0.14 | 0.14 | 0.05 | 0.03 | 0.02 | 0.02 |
Company Updates
Investor Presentation
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Fredun Pharmaceuticals Ltd | 24.16 | 3.11 | 0.09% |
Sun Pharmaceutical Industries Ltd | 47.65 | 6.80 | 0.71% |
Cipla Ltd | 31.27 | 4.81 | 0.81% |
Torrent Pharmaceuticals Ltd | 71.45 | 17.26 | 0.80% |
Price Comparison
Compare FREDUN with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
FREDUN has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.09%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.87 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 23, 2024
Dividend/Share
₹0.70
Ex DateEx Date
Sep 23, 2024
Cash Dividend
Ex DateEx DateSep 22, 2023
Dividend/Share
₹0.70
Ex DateEx Date
Sep 22, 2023
Cash Dividend
Ex DateEx DateSep 16, 2021
Dividend/Share
₹0.70
Ex DateEx Date
Sep 16, 2021
Cash Dividend
Ex DateEx DateSep 16, 2019
Dividend/Share
₹0.65
Ex DateEx Date
Sep 16, 2019
Cash Dividend
Ex DateEx DateSep 18, 2018
Dividend/Share
₹0.60
Ex DateEx Date
Sep 18, 2018
Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 3 October 2024.Powered by Capital Market - Live
Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Fredun Pharmaceuticals standalone net profit rises 72.08% in the June 2024 quarter
Net profit of Fredun Pharmaceuticals rose 72.08% to Rs 4.13 crore in the quarter ended June 2024 as against Rs 2.40 crore during the previous quarter ended June 2023. Sales rose 26.64% to Rs 77.54 crore in the quarter ended June 2024 as against Rs 61.23 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales77.5461.23 27 OPM %13.5212.43 - PBDT6.575.00 31 PBT5.524.08 35 NP4.132.40 72 Powered by Capital Market - Live
Q1 results today: Adani Total Gas, Adani Wilmar among 95 companies to announce earnings on Monday
Fredun Pharmaceuticals standalone net profit rises 85.03% in the December 2022 quarter
Multibagger stock hits 5% upper circuit as Board signs contracts worth ₹90 Cr
Fredun Pharmaceuticals standalone net profit rises 71.20% in the September 2022 quarter
Fredun Pharmaceuticals standalone net profit rises 121.69% in the September 2021 quarter
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 29.08%, vs industry avg of 9.03%
Increasing Market Share
Over the last 5 years, market share increased from 0.04% to 0.09%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 28.56%, vs industry avg of 15.28%